Literature DB >> 8304917

Action of insulin on glucose metabolism in vivo.

H Yki-Järvinen.   

Abstract

Insulin plays a key role in the maintenance of normal glucose tolerance by suppressing endogenous glucose production during a meal. Insulin is not, however, involved in the regulation of splanchnic glucose uptake. The latter process appears, based on studies performed in dogs, to be regulated primarily by the arterial-portal glucose gradient and to a smaller extent by glucose mass-action. Regarding peripheral glucose utilization, insulin is not needed to maintain a normal rate of glucose utilization since this can also be achieved by hyperglycaemia and glucose mass-action. Insulin is, however, necessary for the maintenance of normal rates of glucose oxidation and storage in insulin-sensitive tissues, and for the prevention of excessive gluconeogenic substrate production.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8304917     DOI: 10.1016/s0950-351x(05)80239-3

Source DB:  PubMed          Journal:  Baillieres Clin Endocrinol Metab        ISSN: 0950-351X


  9 in total

1.  Use of positron emission tomography (PET) in the assessment of skeletal muscle glucose metabolism.

Authors:  M J Müller; O Selberg; W Burchert
Journal:  Z Ernahrungswiss       Date:  1997-12

2.  Effects of metformin treatment on glucose transporter proteins in subcellular fractions of skeletal muscle in (fa/fa) Zucker rats.

Authors:  J Rouru; M Koulu; J Peltonen; E Santti; V Hänninen; U Pesonen; R Huupponen
Journal:  Br J Pharmacol       Date:  1995-08       Impact factor: 8.739

3.  A glucose-responsive insulin therapy protects animals against hypoglycemia.

Authors:  Ruojing Yang; Margaret Wu; Songnian Lin; Ravi P Nargund; Xinghai Li; Theresa Kelly; Lin Yan; Ge Dai; Ying Qian; Qing Dallas-Yang; Paul A Fischer; Yan Cui; Xiaolan Shen; Pei Huo; Danqing Dennis Feng; Mark D Erion; David E Kelley; James Mu
Journal:  JCI Insight       Date:  2018-01-11

Review 4.  Incretin based therapies: a novel treatment approach for non-alcoholic fatty liver disease.

Authors:  Kristina Blaslov; Tomislav Bulum; Karin Zibar; Lea Duvnjak
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

5.  Tissue specificity of insulin resistance in humans: fat in the liver rather than muscle is associated with features of the metabolic syndrome.

Authors:  A Kotronen; A Seppälä-Lindroos; R Bergholm; H Yki-Järvinen
Journal:  Diabetologia       Date:  2007-11-16       Impact factor: 10.122

6.  Association between serum lipids, glucose tolerance, and insulin sensitivity during 12 months of celiprolol treatment.

Authors:  K Malminiemi
Journal:  Cardiovasc Drugs Ther       Date:  1995-04       Impact factor: 3.727

7.  Antihyperglycemic effect of the alcoholic seed extract of Swietenia macrophylla on streptozotocin-diabetic rats.

Authors:  Kalpana Kalaivanan; Kodukkur Vishwanthan Pugalendi
Journal:  Pharmacognosy Res       Date:  2011-01

8.  Roles of insulin, age, and asymmetric dimethylarginine on nitric oxide synthesis in vivo.

Authors:  Paolo Tessari; Diego Cecchet; Carlo Artusi; Monica Vettore; Renato Millioni; Mario Plebani; Lucia Puricelli; Monica Vedovato
Journal:  Diabetes       Date:  2013-03-08       Impact factor: 9.461

9.  The selective control of glycolysis, gluconeogenesis and glycogenesis by temporal insulin patterns.

Authors:  Rei Noguchi; Hiroyuki Kubota; Katsuyuki Yugi; Yu Toyoshima; Yasunori Komori; Tomoyoshi Soga; Shinya Kuroda
Journal:  Mol Syst Biol       Date:  2013-05-14       Impact factor: 11.429

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.